1-9 of 9
Jean-Jacques Fournié
Close
Sort by
Journal Articles

Obinutuzumab (GA101) Displays Higher Efficiency Than Rituximab in a Follicular Lymphoma 3D Model

Emilie Decaup, Christine Jean, PhD, Camille Laurent, MD, Pauline Gravelle, Séverine Fruchon, PhD, Florence Capilla, Alain Marrot, Talal AlSaati, MD, François-Xavier Frenois, Guy Laurent, MD PHD, Christian Klein, PhD, Jean-Jacques Fournié, PhD, Nathalie Varoqueaux, MD PHD, Christine Bezombes, PhD
Journal: Blood
Blood (2012) 120 (21): 4868.
https://doi.org/10.1182/blood.V120.21.4868.4868
Published: 2012
Journal Articles

Involvement of the Syk-mTOR Pathway in Follicular Lymphoma Cell Invasion and Angiogenesis,

Christine Bezombes, Séverine Fruchon, Samar Kheirallah, Talal AlSaati, Loic Ysebaert, MD PhD, Camille Laurent, MD, Jean-Jacques Fournié, PhD, Guy Laurent, MD PHD
Journal: Blood
Blood (2011) 118 (21): 3656.
https://doi.org/10.1182/blood.V118.21.3656.3656
Published: 2011
Journal Articles

“Don't Eat me”: CD47 and LFA-1 Modulate CLL Response to Nurselike Cells-Mediated Antibody-Dependent Phagocytosis Induced by Rituximab and Obinutuzumab (GA101)

Loic Ysebaert, MD PhD, Emilie Laprevotte, Christian Klein, PhD, Guy Laurent, MD PHD, Anne Quillet-Mary, Mary Poupot, Jean-Jacques Fournié, PhD
Journal: Blood
Blood (2011) 118 (21): 1762.
https://doi.org/10.1182/blood.V118.21.1762.1762
Published: 2011
Journal Articles

The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status

Marta Coscia, MD, PhD, Candida Vitale, MD, Silvia Peola, PhD, Chiara Riganti, MD, Daniela Angelini, PhD, Myriam Foglietta, MD, Francesca Pantaleoni, PhD, Giorgia Matta, MD, Sabina Chiaretti, MD, Anna Guarini, PhD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Luca Battistini, MD, Robin Foà, MD, Mario Boccadoro, MD, Jean-Jacques Fournié, PhD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 3602.
https://doi.org/10.1182/blood.V116.21.3602.3602
Published: 2010
Journal Articles

Chronic Lymphocytic Leukemia-Associated Macrophages: Not Just Nurse Cells

Loic Ysebaert, Mary Poupot, Yovan Sanchez-Ruiz, Camille Laurent, Guy Laurent, MD, Jean-Jacques Fournié, PhD
Journal: Blood
Blood (2010) 116 (21): 46.
https://doi.org/10.1182/blood.V116.21.46.46
Published: 2010
Journal Articles

Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells

Loic Ysebaert, Emilie Laprévotte, Christian Klein, PhD, Guy Laurent, MD, Jean-Jacques Fournié, PhD, Anne Quillet-Mary
Journal: Blood
Blood (2010) 116 (21): 2459.
https://doi.org/10.1182/blood.V116.21.2459.2459
Published: 2010
Journal Articles

Growth Differentiation Factor 15 Plasma Level in patients with Multiple Myeloma: A Study of Intergroupe Francophone Du Myelome

Jill Corre, Murielle Roussel, Anne Huynh, Melanie Gadelorge, Elodie Labat, Patrick Laharrague, Philippe Moreau, Thierry Facon, Hervé Avet-Loiseau, Jean-Jacques Fournié, Michel Attal, Philippe Bourin
Journal: Blood
Blood (2008) 112 (11): 2700.
https://doi.org/10.1182/blood.V112.11.2700.2700
Published: 2008
Journal Articles

FcγRIII discriminates between 2 subsets of Vγ9Vδ2 effector cells with different responses and activation pathways

Daniela F. Angelini, Giovanna Borsellino, Mary Poupot, Adamo Diamantini, Rémy Poupot, Giorgio Bernardi, Fabrizio Poccia, Jean-Jacques Fournié, Luca Battistini
Journal: Blood
Blood (2004) 104 (6): 1801–1807.
https://doi.org/10.1182/blood-2004-01-0331
Published: 2004
Includes: Supplemental data
Journal Articles

Ex vivo development of functional human lymph node and bronchus-associated lymphoid tissue

Rabindra Tirouvanziam, Ibrahim Khazaal, Victoire N'Sondé, Marie-Alix Peyrat, Annick Lim, Sophie de Bentzmann, Jean Jacques Fournié, Marc Bonneville, Bruno Péault
Journal: Blood
Blood (2002) 99 (7): 2483–2489.
https://doi.org/10.1182/blood.V99.7.2483
Published: 2002